ImmunityBio reports 700% annual revenue growth for cancer drug Anktiva

By Chinmay / 15/01/2026

ImmunityBio reports 700% annual revenue growth for cancer drug Anktiva

Source link

Post navigation

Search

Recent Posts

US troops return to Qatar base; Iran reopens airspace — is America stepping back from Tehran strike?
Angel One Q3 Results: एंजल वन का मुनाफा घटा, तगड़े डिविडेंड और स्टॉक स्प्लिट का ऐलान – angel one q3 fy26 results profit down 4 5 percent revenue up 6 percent dividend rs 23 stock split announced
Mercury Systems stock hits all-time high at 99.46 USD
Banc of California stock hits 52-week high at 20.69 USD
Amcor completes 1-for-5 reverse stock split